chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
CHRONMYELOPRO
Extra metadata
List of similar endpoints to
Chronic myeloproliferative disease
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 137 | 61 | 76 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.07 |
| Mean age at first event (years) | 63.75 | 62.83 | 64.48 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: CHRONMYELOPRO – Chronic myeloproliferative disease
GWS hits: 1
before Chronic myeloproliferative disease
after Chronic myeloproliferative disease
Loading survival analyses plot
Loading survival analyses table